PARIS--(BUSINESS WIRE)--ExonHit Therapeutics (Alternext: ALEHT) is expanding its therapeutic research activities in neurological disorders to include epilepsy.
PARIS--(BUSINESS WIRE)--ExonHit Therapeutics (Alternext: ALEHT) is expanding its therapeutic research activities in neurological disorders to include epilepsy.